Archives of Clinical Infectious Diseases

Published by: Kowsar

Detection of Human Papilloma Virus Type 16 in Epithelial Ovarian Tumors Samples

Masoud Dadashi 1 , 2 , Gita Eslami 2 , * , Ebrahim Faghihloo 2 , Ali Pourmohammad 2 , Jalil Hosseini 1 , Robabeh Taheripanah 1 and Zahra Arab-Mazar 3
Authors Information
1 Infertility and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Microbiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2017, 12 (1); e39666
  • Published Online: December 25, 2016
  • Article Type: Research Article
  • Received: June 1, 2016
  • Revised: December 18, 2016
  • Accepted: December 18, 2016
  • DOI: 10.5812/archcid.39666

To Cite: Dadashi M, Eslami G, Faghihloo E, Pourmohammad A, Hosseini J, et al. Detection of Human Papilloma Virus Type 16 in Epithelial Ovarian Tumors Samples, Arch Clin Infect Dis. 2017 ; 12(1):e39666. doi: 10.5812/archcid.39666.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012; 285(3): 771-7[DOI][PubMed]
  • 2. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4): 244-65[PubMed]
  • 3. Liu X, Zhang S, Ruan Q, Ji Y, Ma L, Zhang Y. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China. Int J Gynecol Cancer. 2010; 20(1): 147-53[DOI][PubMed]
  • 4. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007; 107(2 Suppl 1)-5[DOI][PubMed]
  • 5. Robison K, Hosmer J, Murray A, Ruhul QM, Raker C. Prevalence of hpv and type distribution in southeast asian women residing in rhode Island. Austin J Obstet Gynecol. 2014; 1(6): 5
  • 6. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis. 2007; 7(7): 453-9[DOI][PubMed]
  • 7. Ishizaki A, Matsushita K, Hoang HT, Agdamag DM, Nguyen CH, Tran VT, et al. E6 and E7 variants of human papillomavirus-16 and -52 in Japan, the Philippines, and Vietnam. J Med Virol. 2013; 85(6): 1069-76[DOI][PubMed]
  • 8. Chen W, Zhang X, Molijn A, Jenkins D, Shi JF, Quint W, et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes Control. 2009; 20(9): 1705-13[DOI][PubMed]
  • 9. Munoz N, Bosch FX, de Sanjose S, Vergara A, del Moral A, Munoz MT, et al. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev. 1993; 2(5): 423-31[PubMed]
  • 10. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6): 518-27[DOI][PubMed]
  • 11. Paul MP, Iannuzzi MC. Sarcoidosis and immunologic lung. 2011;
  • 12. Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, et al. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010; 70(8): 3159-69[DOI][PubMed]
  • 13. Dadashi M , Eslami G , Ghalavand Z , Goudarzi H , Fallah F , Owlia P . Prevalence of chlamydia trachomatis and mycoplasma genitalium in patients with benign and malignant ovarian cancer by nested pcr method. Novel Biomed. 2016; 4(1): 18-23
  • 14. Thanapprapasr D, Wilailak S. Screening for ovarian cancer in women, ovarian cancer-clinical and therapeutic perspectives. 2012;
  • 15. Radojicic J, Zaravinos A, Spandidos DA. HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. Int J Biol Markers. 2012; 27(1): 1-12[DOI][PubMed]
  • 16. Parkin DM, Monteleone P, Maj M, Fusco M, Orazzo C, Kemali D. The global health burden of infection-associated cancers in the year 2002. J Prev Med Public Health. 2001; 34(4): 372-8
  • 17. Nakashima K, Shigehara K, Kawaguchi S, Wakatsuki A, Kobori Y, Nakashima K, et al. Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp. BMC Infect Dis. 2014; 14: 43[DOI][PubMed]
  • 18. Lee JY, Kim SM, Park SJ, Lee SO, Choi SH, Kim YS, et al. A rapid and non-invasive 2-step algorithm for diagnosing tuberculous peritonitis using a T cell-based assay on peripheral blood and peritoneal fluid mononuclear cells together with peritoneal fluid adenosine deaminase. J Infect. 2015; 70(4): 356-66[DOI][PubMed]
  • 19. Bilyk OO, Pande NT, Pejovic T, Buchinska LG. The frequency of human papilloma virus types 16, 18 in upper genital tract of women at high risk of developing ovarian cancer. Exp Oncol. 2014; 36(2): 121-4[PubMed]
  • 20. Macfarlane TV, Macfarlane GJ, Thakker NS, Benhamou S, Bouchardy C, Ahrens W, et al. Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study. Ann Oncol. 2012; 23(4): 1053-60[DOI][PubMed]
  • 21. Atalay F, Taskiran C, Taner MZ, Pak I, Or M, Tuncer S. Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. J Obstet Gynaecol Res. 2007; 33(6): 823-8[DOI][PubMed]
  • 22. Anttila M, Syrjanen S, Ji H, Saarikoski S, Syrjanen K. Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol. 1999; 72(3): 337-41[DOI][PubMed]
  • 23. Idahl A, Lundin E, Elgh F, Jurstrand M, Moller JK, Marklund I. Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol. 2010; 202(1): 71
  • 24. Rosa MI, Silva GD, de Azedo Simoes PW, Souza MV, Panatto AP, Simon CS, et al. The prevalence of human papillomavirus in ovarian cancer: a systematic review. Int J Gynecol Cancer. 2013; 23(3): 437-41[DOI][PubMed]
  • 25. de Villiers EM, Schneider A, Gross G, zur Hausen H. Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol. 1986; 174(6): 281-6[PubMed]
  • 26. Runnebaum IB, Maier S, Tong XW, Rosenthal HE, Mobus VJ, Kieback DG, et al. Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. Cancer Epidemiol Biomarkers Prev. 1995; 4(5): 573-5[PubMed]
  • 27. Roteh SMSA, Fard ZT, Abdirad A, Moeini Z. Analysis of ovarian epithelial tumors for presence of human papillomavirus. J Mazandaran Univ Med Sci. 2012; 22(87): 22-27
  • 28. Alavi G, Sharifi N, Sadeghian A, Rezaei A, Shidaee H. Failure to demonstrate the role of high risk human papilloma virus in epithelial ovarian cancer. Iran J Pathol. 2012; 7(3): 151-6
  • 29. Ip SM, Wong LC, Xu CM, Cheung AN, Tsang PC, Ngan HY. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract. Gynecol Oncol. 2002; 87(1): 104-11[PubMed]
  • 30. Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer. 2002; 95(12): 2571-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments